恒瑞医药10月20日斥资65万元回购1万股A股

Core Viewpoint - Heng Rui Medicine (600276) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company plans to repurchase 10,000 A-shares at a total cost of 650,000 yuan [1] - The buyback price is set at 65 yuan per share [1] - The buyback is scheduled for October 20, 2025 [1]